Monday, March 27, 2006

FDA Delays Final Decision on Tysabri Until Late June

FDA Delays Final Decision on Tysabri Until Late June
Newsinferno.com - New York,NY,USA
Once an advisory panel voted unanimously to recommend that Tysabri, the controversial MS drug, be allowed back on the market, it was assumed that the FDA would ...

FDA will try to make Tysabri decision before end of June
MarketWatch - USA
... Drug Administration said Friday it would try to make a final decision before the end of June on whether to allow the multiple-sclerosis drug Tysabri back on ...
See all stories on this topic

Elan falls by 8pc as FDA delays Tysabri
Unison.ie - Bray,Ireland
... drugmaker Elan dropped 8pc yesterday to finish at €11.20 after the company suffered a new setback on the return of its multiple sclerosis drug Tysabri to the ...

Ruling on MS Drug Tysabri Delayed
Los Angeles Times - CA,USA
... said in a joint statement that the Food and Drug Administration had postponed until June 28 a decision on whether to re-approve the drug, called Tysabri. ...

0 Comments:

Post a Comment

<< Home